Topics And Speakers:
01. Module 1 Evaluation is Essential for Safe and Effective Pain Management Using ERLA Opioids – Charles E Argoff MD
02. Module 2 Best Practices for How to Start Therapy with ERLA Opioids, How to Stop, and What to Do in Between – John A Hopper MD
03. Module 3 Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ERLA Opioids – John A Hopper MD
04. Module 4 Talk to Me Proven Methods to Counsel Your Patients on ERLA Opioids and Achieve Positive Outcomes – Steven Stanos
05. Module 5 Everything You Always Wanted to Know About ERLA Opioids as a Drug Class – Charles E Argoff MD
06. Module 6 Getting the Most Clinical Insights from Specific ERLA Product Information Sources – Charles E Argoff MD
Blue texts are Keyword Links.
This SAFE Opioid Prescribing Pre-Course – a Risk Evaluation and Mitigation Strategy (REMS) activity – allows you to leave the site and return to complete it in segments, depending on your schedule. To earn credits and points, you must complete all six modules and correctly answer at least seven of 12 medical knowledge questions. The SAFE Opioid Prescribing pre-course provides guidance that is essential for safe and effective pain management when using extended (ER) and long-activing (LA) opioids.
The need for education that will help medical professionals respond to the opioid epidemic is increasing. Here is a free program that can help.
This CME activity features six, half-hour educational segments, plus questions and answers facilitated by expert faculty.
This SAFE Opioid Prescribing Course – a Risk Evaluation and Mitigation Strategy (REMS) activity – allows you to leave the site and return to complete the course in segments, depending on your schedule. To earn CME credits and ABIM Medical Knowledge MOC points, you must complete all six modules and correctly answer at least seven of 12 medical knowledge questions.
The SAFE Opioid Prescribing course provides guidance that is essential for safe and effective pain management when prescribing extended-release (ER) and long-acting (LA) opioids. It is critical to recognize best practices for how to start to therapy with ER/LA, how to provide therapy, how to end therapy, and what to do in between. Evidence-based tools are required for screening patients at risk and for monitoring for adherence to prescribed ER/LA opioids. Proven methods to counsel patients on ER/LA opioids and to achieve positive outcomes need to be employed. Comprehensive information is also essential on ER/LA-opioids as a drug class. This recorded course will provide clinical insights from specific ER/LA product information sources.
No registration fee is required to use this recorded course, which will expire July 15, 2018.
Upon completion of this initiative, the participants will be better able to:
Implement patient assessment strategies, including tools to assess risk of abuse, misuse, or addiction when prescribing extended-release (ER/LA) opioids.
Employ approaches to safely initiate therapy, modify dose, and discontinue ER/LA opioids.
Monitor patients by evaluating treatment goals and implementing periodic urine drug testing (UDT).
Employ patient education strategies about the safe use of ER/LA opioids.
Identify similarities and differences among ER/LA opioids.
Total of 6 presentations, plus Q&A
Up to 3.5 CME credits and 3.5 MOC points available
Professionally-mixed video alternating between presenter and PowerPoints
Interactive case-based questions throughout the course
Case-to-case jump points for easy navigation within each presentation
Leave the presentation and pick up later where you left off
Release date: July 15, 2017
Expiration date: July 15, 2018